| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 06/25/2008 | CN101204547A Peroral Chinese traditional medicine for yangcollaterals injury inducing emptysis |
| 06/25/2008 | CN101204546A Chinese traditional medicine preparation for allergic rhinitis |
| 06/25/2008 | CN101204544A Peroral Chinese traditional medicine for kidney-inducing emptysis |
| 06/25/2008 | CN101204537A Chinese traditional medicine composite for reducing spitting, dispelling wind, and relieving convulsion and preparation method thereof |
| 06/25/2008 | CN101204536A Chinese traditional medicine composite for reducing spitting, dispelling wind, and relieving convulsion and preparation method thereof |
| 06/25/2008 | CN101204513A Peroral Chinese traditional medicine composition for emphysema |
| 06/25/2008 | CN101204510A Preparation and quality control method of Chinese traditional medicine preparation |
| 06/25/2008 | CN101204509A Chinese traditional medicine soft capsule and preparation method thereof |
| 06/25/2008 | CN101204508A Liquid Chinese traditional medicine capsule and preparation method thereof |
| 06/25/2008 | CN101204479A Chinese traditional medicine preparation for acute sinusitis |
| 06/25/2008 | CN101204478A Nose-scenting medicine for chronic nasosinusitis |
| 06/25/2008 | CN101204471A Chinese traditional medicine curing gastro-enteritis & faucitis simultaneously and preparation method thereof |
| 06/25/2008 | CN101204462A Chinese traditional medicine preparation for liver and kidney eficiencyofyin epistaxis |
| 06/25/2008 | CN101204453A Tincture medicine for perennial allergic rhinitis |
| 06/25/2008 | CN101204449A Chinese traditional medicine preparation for diphtheria and processing thereof |
| 06/25/2008 | CN101204448A Chinese traditional traditional medicine for SARS |
| 06/25/2008 | CN101204444A Cataplasm for amygdalitis |
| 06/25/2008 | CN101204443A Chinese traditional medicine composite for clearing lung, eliminating phlegm, relieving cough & asthma and preparation method thereof |
| 06/25/2008 | CN101204425A Medicine for infant obstinate bricanyl |
| 06/25/2008 | CN101204424A Composite of traditional Chinese traditional medicine for clearing away heat and toxic, antiinflammatory, detumescence and preparation method thereof |
| 06/25/2008 | CN101204422A Chinese traditional medicine preparation preparation for acute tonsillitis |
| 06/25/2008 | CN101204414A Pasty medicine for treating asthma |
| 06/25/2008 | CN101204413A Preparation technology of total yuenkanin flavone-Glycoides and determination method of total yuenkanin flavone-Glycoides contents in finished products thereof |
| 06/25/2008 | CN101204386A Liquid composite containing salbutamol sulfate and ambroxol hydrochloride |
| 06/25/2008 | CN101204379A Ambroxol cefadroxil dispersible tablets |
| 06/25/2008 | CN101204250A Natural tobacco humectant additive and its preparation method and using thereof |
| 06/25/2008 | CN101204225A Medical food with the function of enriching blood and moistening lung |
| 06/25/2008 | CN101204182A Lung-clearing thirst-quenching tea and manufacture method |
| 06/25/2008 | CN100396692C Diuridine tetraphosphate or salt crystal thereof, process for producing the same, and process for producing the compounds |
| 06/25/2008 | CN100396679C Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 06/25/2008 | CN100396677C 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 06/25/2008 | CN100396676C Synthesis of piperidine and piperazine compounds as CCR5 antagonists |
| 06/25/2008 | CN100396668C Non-imidazole aryloxypiperidines |
| 06/25/2008 | CN100396329C Suspension of an EPI-HNE protein, process of preparation thereof, dry powder aerosol derived therefrom, pharmaceutical composition containing said suspension or aerosol, and their uses |
| 06/25/2008 | CN100396313C Chinese herbal medicine preparation for treating pneumoconiosis and tuberculosis |
| 06/25/2008 | CN100396307C Chinese medicine for treating inflammation in respiratory system |
| 06/25/2008 | CN100396298C New technology for refining xiasanju extract using membrane separation technique |
| 06/25/2008 | CN100396285C Inhalative solution formulation containing tiotropium salt |
| 06/24/2008 | US7392233 Image searching system, image searching method, and a recording medium storing an image searching program |
| 06/24/2008 | US7390924 Terphenyl derivatives, preparation thereof, compositions containing same |
| 06/24/2008 | US7390906 Forming ketone intermediates to terfenadine carboxylic acid metabolite; by use of pure regioisomer of 4-(Cyclopropyl-oxo-methyl)-alpha,alpha-dimethylphenylacetic acid |
| 06/24/2008 | US7390815 Pyrazole compounds useful as protein kinase inhibitors |
| 06/24/2008 | US7390808 Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes |
| 06/24/2008 | US7390668 Halogenated xanthan compound |
| 06/24/2008 | US7390625 Apoptosis-associated protein and use thereof |
| 06/24/2008 | US7390519 Probiotic Lactobacillus salivarius strains |
| 06/24/2008 | US7390508 Xenon is administered with an anesthetic selected from isoflurane, sevoflurane, and desflurane; treating hypoxic-ischemic (HI) insult |
| 06/24/2008 | US7390484 Self-contained adipose derived stem cell processing unit |
| 06/19/2008 | WO2008074031A1 Compositions and methods for treating infectious bronchitis |
| 06/19/2008 | WO2008072988A1 Honey based compositions of a consistency that can be delivered to the respiratory system |
| 06/19/2008 | WO2008072872A1 Method of preparing montelukast and intermediates used therein |
| 06/19/2008 | WO2008072779A1 Quinoxaline derivative |
| 06/19/2008 | WO2008072724A1 Pyrazole derivative |
| 06/19/2008 | WO2008072703A1 Biphenylamide derivative |
| 06/19/2008 | WO2008072682A1 Imidazo[1,2-b]pyridazine derivative |
| 06/19/2008 | WO2008071976A1 8-oxoadenine derivatives as immuno-modulators |
| 06/19/2008 | WO2008071944A1 Benzoxazoles useful in the treatment of inflammation |
| 06/19/2008 | WO2008071664A1 Nicotinamide derivative used as a p38 kinase inhibitor |
| 06/19/2008 | WO2008071605A2 Methods of treating inflammatory diseases |
| 06/19/2008 | WO2008071197A1 Methods for treating cystic fibrosis or pneumonia with bacterial infection via pulmonary administration of fosfomycin |
| 06/19/2008 | WO2006128674A8 Combinations of indacaterol derivatives and other agents for the treatment of airway diseases |
| 06/19/2008 | US20080146836 New Aminopropylphosphinic acids |
| 06/19/2008 | US20080146669 Treating cystic fibrosis by administering a therapeutically effective amount of a compound capable of stimulating the activity of a cystic fibrosis transmembrane conductance regulator such as an arylaminobenzoate or a benzenesulfonamide derivative or curcumin |
| 06/19/2008 | US20080146649 Substituted pyrrolidine and related compounds |
| 06/19/2008 | US20080146639 Reducing the incidence of fibrosis by the co-administration of effective amounts of telmisartan and ramipril; strokes; cardiovascular disorders; organoprotective, tissue-protective, and vasculoprotective effects of combined treatment |
| 06/19/2008 | US20080146614 Therapeutic Agents |
| 06/19/2008 | US20080146612 Novel Biaromatic Compounds, Inhibitors of the P2X7-Receptor |
| 06/19/2008 | US20080146606 Novel compounds |
| 06/19/2008 | US20080146604 adenosine receptor antagonists such as 2-(4-Methoxyphenyl)-9-benzylamino-10-cyano-s-triazolo[1,5-a]quinolin, used for treating respiratory system disorders, vision disorders, tumors, allergies or inflammatory disease, ischemia, hypoxia, arrhythmia or urogential disorders |
| 06/19/2008 | US20080146603 Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
| 06/19/2008 | US20080146590 P38 map kinase inhibitors and methods for using the same |
| 06/19/2008 | US20080146569 Nicotinamide Derivatives |
| 06/19/2008 | US20080146566 treatment of diseases mediated by cytokines; N-cyclopropyl-4-methyl-3-(1-oxoisoquinolin-2(1H)-yl)benzamide; rheumatoid arthritis, asthma, chronic obstructive pulmonary disease, inflammatory bowel disease, multiple sclerosis, AIDS, septic shock, congestive heart failure, ischaemic heart disease, psoriasis |
| 06/19/2008 | US20080146554 Substituted Cycloalkyl Derivatives, Process for the Manufacture thereof and Use thereof as Medicament |
| 06/19/2008 | US20080146540 Identifying genetically at risk persons having MAP3K9 associated presence; kits; assay techniques; treating with mixed lineage kinase inhibitors |
| 06/19/2008 | US20080146532 Drug Screening and Treatment Methods |
| 06/19/2008 | US20080145450 Delivery or removal of metals from biological systems |
| 06/19/2008 | DE102006053475A1 Zubereitungen zur Hemmung der Prostaglandin E2 Synthese Preparations for the inhibition of prostaglandin E2 synthesis |
| 06/19/2008 | CA2672261A1 Methods for treating cystic fibrosis or pneumonia with bacterial infection via pulmonary administration of fosfomycin |
| 06/19/2008 | CA2672233A1 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use |
| 06/19/2008 | CA2671980A1 Quinoxaline derivatives |
| 06/19/2008 | CA2668935A1 Compositions and methods for treating infectious bronchitis |
| 06/18/2008 | EP1932856A2 IL-8 inhibitors |
| 06/18/2008 | EP1932840A1 Nitrogen-containing heterocyclic compound and pharmaceutical application thereof |
| 06/18/2008 | EP1932839A1 Indolecarboxylic acid derivative having pgd2 receptor antagonistic activity |
| 06/18/2008 | EP1932540A1 SECRETORY IgA AND IgG ANTIBODIES-INDUCING AGENT |
| 06/18/2008 | EP1931672A1 Novel 5,6-dihydropyrazolo[3,4-e] [l,4]diazepin-4 (ih) -one derivatives for the treatment of asthma and chronic obstructive pulmonary disease. |
| 06/18/2008 | EP1931668A2 Substituted pyrazolo [3,4-b]pyridines as phosphodiesterase inhibitors |
| 06/18/2008 | EP1931666A1 Imidazopyridine derivatives as a2b adenosine receptor antagonists |
| 06/18/2008 | EP1931663A1 Imdolizine derivatives as ligands of the crth2 receptor |
| 06/18/2008 | EP1931345A2 Methods for treatment of thiol-containing compound deficient conditions |
| 06/18/2008 | EP1343895B1 Streptococcus pyogenes antigens and corresponding dna fragments |
| 06/18/2008 | CN101203517A 1- ( 2-amino-3- (substituted alkyl)-3h-benzimidazoiylmethyl) -3-subtituted-1,3-dihydro-benzoimidazol-2-ones with activity on respiratory syncytial virus |
| 06/18/2008 | CN101203513A Novel crystalline forms of tiotropium bromide |
| 06/18/2008 | CN101203511A New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases |
| 06/18/2008 | CN101203507A 2-substituted benzimidazoles |
| 06/18/2008 | CN101203506A Heterocyclylaminoalkyl substituted benzimidazoles |
| 06/18/2008 | CN101203493A Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them |
| 06/18/2008 | CN101203229A Clarithromycin or salt thereof for the treatment or prevention of pulmonary disorders caused by the destruction of pulmonary alveoli |
| 06/18/2008 | CN101203223A Pharmaceutical composition comprising amorphous rosiglitazone |